By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...
Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...
OpenAI (OPENAI) is trying to deepen the use of artificial intelligence in the life sciences, according to a new research ...
Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio ...
Strengthen Achieve's Position to Execute Development and Launch of Cytisinicline, if Approved, as the First New Treatment for Nicotine Dependence in Two Decades SEATTLE and VANCOUVER, British Columbia ...
The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2026 ISPE AI in ...
Rosalind, an artificial intelligence model designed to enhance research in biochemistry, drug discovery and translational medicine.
Construction starts at Detroit's 'fail jail' site — a new BAMF‑Henry Ford theranostics center leads the project.
The two-story, 90,000-square-foot Gratiot Life Sciences Building is expected to be completed by the end of 2027, officials ...
OpenAI announced a new series of AI models built to help life sciences researchers work faster. Why it matters: Biology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results